Product line
FLEBION – Redness Prone & Microcirculation Skin Solutions
How common is this condition?
Rosacea affects approximately 5.46% of adults worldwide and is most common between the ages of 45 and 60. Incidence is highest in Europe, although epidemiological research into couperose and rosacea has also begun in other regions of the world, where official data are not yet available.
Dermocosmetic solution offered: no-rinse cleansing + leave-on creams
The FLEBION line combines vasoactive, soothing and protective ingredients to counteract persistent and transient redness, couperose and capillary fragility. The formulations support cutaneous microcirculation and incorporate photoprotection, which is important because sun exposure can exacerbate vascular hyperreactivity and erythema in sensitive skin.




